 |
|
Prolonged Drug-Drug Interaction between Terbinafine and Perphenazine
Young-Min Park
Psychiatry Investig. 2012;9(4):422-424. Published online 2012 Nov 12 DOI: https://doi.org/10.4306/pi.2012.9.4.422
|
|
CYP2C19 and 3A4 Dominate Metabolic Clearance and Bioactivation of Terbinafine Based on Computational and Experimental Approaches
Mary A. Davis, Dustyn A. Barnette, Noah R. Flynn, Anirudh S. Pidugu, S. Joshua Swamidass, Gunnar Boysen, Grover P. Miller
Chemical Research in Toxicology.2019; 32(6): 1151. CrossRef Analysis of the Mechanism of Prolonged Persistence of Drug Interaction between Terbinafine and Amitriptyline or Nortriptyline
Akiko Mikami, Satoko Hori, Hisakazu Ohtani, Yasufumi Sawada
Biological & Pharmaceutical Bulletin.2017; 40(7): 1010. CrossRef Variation in the inhibitory potency of terbinafine among genetic variants of CYP2D6
Takeshi Akiyoshi, Miho Ishiuchi, Ayuko Imaoka, Hisakazu Ohtani
Drug Metabolism and Pharmacokinetics.2015; 30(4): 321. CrossRef A metoprolol–terbinafine combination induced bradycardia
Emmanuel Bebawi, Suhail S. Jouni, Andrée-Anne Tessier, Anne Julie Frenette, Dave Brindamour, Maxime Doré
European Journal of Drug Metabolism and Pharmacokinetics.2015; 40(3): 295. CrossRef Interaction of Terbinafine (Anti-fungal agent) with Perhexiline: A Case Report
Abdul Rauf Sheikh, Ian Westley, Benedetta Sallustio, John D Horowitz, John F Beltrame
Heart, Lung and Circulation.2014; 23(6): e149. CrossRef Efinaconazole 10% solution: a new topical antifungal therapy for onychomycosis
Boni E Elewski
Expert Review of Dermatology.2013; 8(4): 347. CrossRef Perphenazine/terbinafine interaction
Reactions Weekly.2013; 1437(1): 25. CrossRef
|